DRD4 gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease

Ann Clin Transl Neurol. 2024 Aug;11(8):2222-2229. doi: 10.1002/acn3.52111. Epub 2024 Jul 1.

Abstract

Impulse control disorders and their consequences display variability among individuals, indicating potential involvement of environmental and genetic factors. In this retrospective study, we analyzed a cohort of Parkinson's disease patients treated with dopamine agonists and investigated the influence of the dopamine D4 receptor gene polymorphism, DRD4 7R+, which is linked to psychiatric disorders, impulsive traits, and addictive behaviors. We found that DRD4 7R+ is a significant genetic risk factor associated with the severity of ICD.

MeSH terms

  • Aged
  • Disruptive, Impulse Control, and Conduct Disorders* / chemically induced
  • Disruptive, Impulse Control, and Conduct Disorders* / genetics
  • Dopamine Agonists* / administration & dosage
  • Dopamine Agonists* / adverse effects
  • Dopamine Agonists* / pharmacology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease* / drug therapy
  • Parkinson Disease* / genetics
  • Polymorphism, Genetic
  • Receptors, Dopamine D4* / genetics
  • Retrospective Studies

Substances

  • Receptors, Dopamine D4
  • Dopamine Agonists
  • DRD4 protein, human